Ascendis Pharma A (ASND) Amortizatization of Intangibles (2021 - 2025)

Ascendis Pharma A has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $150161.6 for Q4 2025.

• Amortizatization of Intangibles for Q4 2025 came in at $150161.6, up 18.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $553832.8 (up 9.56% YoY), and the FY2025 annual result was $570381.3, up 14.3% from the prior year.
• Amortizatization of Intangibles came in at $150161.6 for Q4 2025 at Ascendis Pharma A, up from $143793.8 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $161391.0 in Q4 2023 to a low of $111918.5 in Q3 2022.
• The 5-year median for Amortizatization of Intangibles is $126729.0 (2024), against an average of $128817.0.
• Across the five-year window, Amortizatization of Intangibles jumped 42.51% in 2023 and decreased 21.21% in 2024, its largest moves.
• Ascendis Pharma A's Amortizatization of Intangibles stood at $128124.7 in 2021, then retreated by 11.61% to $113247.5 in 2022, then surged by 42.51% to $161391.0 in 2023, then slipped by 21.21% to $127162.9 in 2024, then climbed by 18.09% to $150161.6 in 2025.
• The last three Amortizatization of Intangibles figures came in at $150161.6 (Q4 2025), $143793.8 (Q3 2025), and $134703.2 (Q2 2025), per Business Quant data.